科拓生物：2025年第三季度归属于上市公司股东的净利润同比增长26.56%

Core Insights - The company reported a revenue of 104,043,568.35 yuan for the third quarter of 2025, representing a year-on-year growth of 28.98% [2] - The net profit attributable to shareholders of the listed company was 35,026,934.69 yuan, showing a year-on-year increase of 26.56% [2] Financial Performance - Revenue for Q3 2025: 104,043,568.35 yuan, up 28.98% year-on-year [2] - Net profit for Q3 2025: 35,026,934.69 yuan, up 26.56% year-on-year [2]